MRI Sequences: A Clinician's Guide

The MRI report can feel like a foreign language until you learn its grammar — and the grammar is the pulse sequence. Each sequence weights the image to highlight different tissue properties, so the same brain looks dramatically different from one to the next. The good news for the bedside clinician is that you don't need to be a physicist to read intelligently. You need to know what each workhorse sequence is good at, where to reach for it, and a handful of reliable rules that let you orient yourself on any scan in seconds. This page walks through the core sequences you'll see on every brain MRI, the tissue signal patterns that define them, and the clinical situations that should make you ask for each one.

Start by looking at the CSF

Before you analyze a single lesion, find the ventricles. The cerebrospinal fluid is your built-in reference standard, and its appearance immediately tells you what kind of image you're looking at. On a T1-weighted image, CSF is dark (black). On a T2-weighted image, CSF is bright (white). This single observation — black CSF means T1, white CSF means T2 — is the fastest way to orient yourself, and it works even when the sequence label is cropped or missing. The one clever exception is FLAIR, discussed below.

T1-weighted: the anatomy sequence

• What it shows: T1 gives the crispest gray–white differentiation and the best anatomic detail, which is why it's the backbone of structural assessment and surgical planning.
• Signal rules: CSF is dark, fat is bright, and most pathology is relatively dark or isointense.
• Things that are bright on T1 ("T1 shortening"): fat, subacute hemorrhage (methemoglobin), melanin (melanoma metastases), proteinaceous fluid, and gadolinium contrast.
• Reach for it when: you want anatomy, you're assessing for fat or subacute blood, or you're about to give contrast — because enhancement is read on T1.

T2-weighted: water is white

• What it shows: T2 is the great lesion-detection sequence because almost every pathologic process increases tissue water, and water is bright on T2 — edema, gliosis, demyelination, tumor, and inflammation all light up.
• Signal rules: CSF is bright; "water is white." Most pathology is bright against the darker background of normal brain.
• The limitation: when a bright lesion sits next to bright CSF — periventricular plaques, cortical lesions — it can blend in and hide. That is precisely the problem FLAIR was designed to solve.
• Reach for it when: you're hunting for any process that raises water content and want maximum sensitivity for lesion detection.

FLAIR: T2 with the CSF turned off

FLAIR (Fluid-Attenuated Inversion Recovery) is essentially a T2-weighted image with the CSF signal deliberately suppressed (nulled to black). You keep the bright-pathology advantage of T2 but remove the bright CSF that used to camouflage lesions sitting near the ventricles and cortex. This makes FLAIR the everyday workhorse for:

• Multiple sclerosis plaques — periventricular and juxtacortical lesions pop out against the now-dark CSF.
• Gliosis and chronic small-vessel ischemic change.
• Subarachnoid hemorrhage — abnormal sulcal hyperintensity, where blood replaces the normally suppressed (dark) CSF in the subarachnoid space. FLAIR is also useful for leptomeningeal disease and meningitis.

DWI and ADC: diffusion is non-negotiable in stroke

Diffusion-weighted imaging (DWI) measures the random microscopic motion of water molecules. When that motion is restricted — cells swelling and packing tightly together — the signal stays bright on DWI. But DWI alone can fool you, so it is always read together with its companion map, the apparent diffusion coefficient (ADC).

• True restricted diffusion: bright on DWI and dark on ADC. This is the signature of acute infarct, the pus inside a pyogenic abscess, hypercellular tumors such as lymphoma, and herpes encephalitis.
• T2 shine-through: a lesion that is bright on DWI but also bright (or not dark) on ADC is NOT truly restricting — its DWI brightness is borrowed T2 signal, not diffusion restriction. Always confirm with ADC before calling an acute stroke.
• Reach for it when: any suspicion of acute ischemia, abscess versus necrotic tumor, or encephalitis. In suspected stroke, DWI is the single most important sequence.

GRE and SWI: the blood-and-calcium detectors

Gradient-echo (GRE) and the more sensitive susceptibility-weighted imaging (SWI) exploit local magnetic field distortions caused by blood breakdown products and calcium. These substances "bloom" — appearing as dark foci larger than their true size.

• Cerebral microbleeds — markers of hypertensive vasculopathy (deep) or cerebral amyloid angiopathy (lobar).
• Acute and chronic hemorrhage, cavernous malformations ("popcorn" lesion with a dark hemosiderin rim).
• Superficial siderosis — dark hemosiderin staining coating the pial surface from chronic, recurrent subarachnoid bleeding.
• Caution: calcium also blooms dark on GRE; SWI phase data can help distinguish calcium from blood.

T1 post-gadolinium: enhancement means a broken barrier

Gadolinium does not "show tumor" per se — it reveals breakdown of the blood–brain barrier. Wherever the barrier is disrupted, contrast leaks into the interstitium and shortens T1, producing bright enhancement on post-contrast T1 images. The differential for enhancement includes:

• Neoplasm — primary tumors and metastases.
• Active inflammation/demyelination — an actively inflamed MS plaque enhances; a chronic one does not.
• Infection — including the classic smooth, thin rim enhancement of a pyogenic abscess (whose core restricts on DWI).
• Leptomeningeal disease, granulomatous disease, and subacute infarct.

The supporting cast

• STIR — an inversion-recovery technique that suppresses fat, valuable for orbital, spinal, and marrow imaging where bright fat would obscure pathology.
• MRA / MRV — non-invasive imaging of arteries (stenosis, aneurysm, dissection) and veins (sinus thrombosis), often without contrast.
• MR perfusion — maps cerebral blood flow and volume; central to the ischemic core-versus-penumbra mismatch assessment in stroke.
• MR spectroscopy — probes tissue metabolites (NAA, choline, lactate) to help characterize tumors and distinguish them from mimics.

Quick reference table